Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 29 12 2020
Statut: ppublish

Résumé

BackgroundReverse-transcription PCR (RT-PCR) assays are used to test for infection with the SARS-CoV-2 virus. RT-PCR tests are highly specific and the probability of false positives is low, but false negatives are possible depending on swab type and time since symptom onset.AimTo determine how the probability of obtaining a false-negative test in infected patients is affected by time since symptom onset and swab type.MethodsWe used generalised additive mixed models to analyse publicly available data from patients who received multiple RT-PCR tests and were identified as SARS-CoV-2 positive at least once.ResultsThe probability of a positive test decreased with time since symptom onset, with oropharyngeal (OP) samples less likely to yield a positive result than nasopharyngeal (NP) samples. The probability of incorrectly identifying an uninfected individual due to a false-negative test was considerably reduced if negative tests were repeated 24 hours later. For a small false-positive test probability (<0.5%), the true number of infected individuals was larger than the number of positive tests. For a higher false-positive test probability, the true number of infected individuals was smaller than the number of positive tests.ConclusionNP samples are more sensitive than OP samples. The later an infected individual is tested after symptom onset, the less likely they are to test positive. This has implications for identifying infected patients, contact tracing and discharging convalescing patients who are potentially still infectious.

Identifiants

pubmed: 33334398
doi: 10.2807/1560-7917.ES.2020.25.50.2000568
pmc: PMC7812420
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Ophthalmology. 2020 Jul;127(7):977-979
pubmed: 32291098
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132196
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
J Infect. 2020 Aug;81(2):318-356
pubmed: 32283147
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Nat Med. 2020 Apr;26(4):506-510
pubmed: 32284616
J Clin Virol. 2020 Jul;128:104412
pubmed: 32416600
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Front Public Health. 2020 Sep 22;8:570543
pubmed: 33072707
J Korean Med Sci. 2020 Apr 06;35(13):e142
pubmed: 32242348
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
J Gen Virol. 2020 Aug;101(8):791-797
pubmed: 32430094
Emerg Infect Dis. 2020 May;26(5):1052-1054
pubmed: 32091386
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Microbes Infect. 2020 May - Jun;22(4-5):206-211
pubmed: 32425648
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Jpn J Infect Dis. 2020 Nov 24;73(6):399-403
pubmed: 32475877
Clin Infect Dis. 2020 May 22;:
pubmed: 32442256
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Science. 2020 Mar 20;367(6484):1287-1288
pubmed: 32193299
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
J Allergy Clin Immunol. 2020 Nov 20;:
pubmed: 33221383

Auteurs

Paul S Wikramaratna (PS)

These authors contributed equally to this article and share first authorship.
Independent Researcher, London, United Kingdom (DPhil (Zoology) Oxon).

Robert S Paton (RS)

These authors contributed equally to this article and share first authorship.
Department of Zoology, University of Oxford, Oxford, United Kingdom.

Mahan Ghafari (M)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

José Lourenço (J)

Department of Zoology, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH